Psychotic symptoms and Alzheimer disease;Sintomas psicoticos y enfermedad de Alzheimer

Neurologia

Volumn 15, Issue 1, 2000, Pages 8-14

  Alberca, R ^a   Gil Neciga E ^a   Salas, D ^a   Perez J A ^b   Lozano, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Alzheimer's disease; Delusions; Hallucinations; Psychotic symptoms

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COGNITION; DELUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HALLUCINATION; PROBABILITY; PSYCHOSIS; SPECTROMETRY; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; AGED; FEMALE; HOSPITALIZATION; HUMAN; MALE; PSYCHOLOGICAL ASPECT;

AGED; ALZHEIMER DISEASE; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 1642602505     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Binneti G, Bianchetti A, Padovani A, Lenzi G, De Leo D, Trabucchi M. Delusions in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 1993; 88: 5-9.
2. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. I: disorders of thought content. Br J Psychiatry 1990; 157: 72-76.
3. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. II: disorders of perception. Br J Psychiatry 1990; 157: 76-81.
4. Chen J-Y, Stern Y, Sano M, Mayeux R. Cumulative risk of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991; 48: 1141-1143.
5. Chui HC, Lyness S, Sobel E, Schneider LS. Prognostic implications of symptomatic behaviors in Alzheimer's disease. En: Boller F, Forette F, Khachaturian Z, Poncet M, Christen Y, editores. Heterogeneity of Alzheimer's disease. Berlín: Springer Verlag 1992; 12-23.
6. Gilley DW, Whales ME, Wilson RS, Bennet DA. Hallucinations and associated factors in Alzheimer's disease. J Neuropsychiatry Clin Sci 1991; 3: 371-376.
7. Gilley DW, Wilson RS, Bennet DA, Bernard BA, Fox JH. Predictors of behavioral disturbance in Alzheimer's disease. J Gerontol 1991; 46: 362-371.
8. Gormley N, Rizwan MR. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 1998; 13: 410-414.
9. Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan TM et al. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc 1997; 45: 1331-1338.
10. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46: 130-135.
11. Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G et al. Multicenter study of predictors disease course in Alzheimer disease (the Predictors Study). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord 1993; 7: 22-32.
12. Stern Y, Albert M, Brandt J, Jacobs DM, Tang M-X, Marder K et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: propsective analyses from the predictors study. Neurology 1994; 44: 2300-2307.
13. Stern Y, Folstein M, Albert M, Richards M, Miller L, Bylsma F et al. Multicenter study of predictors of disease course in Alzheimer disease (the Predictors study): I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993; 7: 3-21.
14. Drachman DA, O'Donnell BF, Lew RA, Swearer JM. The prognosis in Alzheimer's disease. "How far" rather than "how fast" best predicts the course. Arch Neurol 1990; 47: 851-856.
15. Blanco A, Alberca R, Marqués E, López-Domínguez JM, Gil-Nécija E, Carrizosa E. Utilidad del SPECT en el estudio de la enfermedad de Alzheimer. Neurología 1998; 13: 63-68.
16. Reisberg B, Ferris SH, Fransen E. An ordinal functional assessement tool for Alzheimer's-type dementia. Hosp Community Psychiatry 1985; 36: 593-595.
17. Reisberg B, Borenstein J, Franssen E, Salob S, Steinberg G. BEHAVE-AD: a clinical raiting scale for the assessment of pharmacologically remediable behavioral symptomatology in Alzheimer's disease. En: Altman HJ, editor. Alzheimer's disease problems: prospects and perspectives. Nueva York: Plenum, 1987; 1-16.
18. Gil-Néciga E, Alberca R, Moreno A, Cayuela A, Serrano V, Garzón F. Behavioral symptoms in Alzheimer's disease. J Neurol Sci 1997; 48 (Supl): 21.
19. Devanand DP, Miller L, Marder K, Bell K, Mayeux R, Stern Y. The Columbia university scale for psychopathology in Alzheimer's disease. Arch Neurol 1992; 49: 371-376.
20. Weiner MF, Koss E, Wild KV, Folks DG, Tariot P, Luszczynska H et al. Measures of psychiatric symptoms in Alzheimer patientes: a review. Alzheimer Dis Assoc Disord 1996; 10: 20-30.
21. Devanand DP. Use of Columbia university scale to assess psychopathology in Alzheimer's disease. Int Psychogeriatr 1997; 9 (Supl 1): 137-142.
22. Wragg RE, Joste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989; 146: 577-587.
23. Binnetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A et al. Behavioral disorders in Alzheimer's disease: a transcultural perspective. Arch Neurol 1998; 55: 539-544.
24. Esiri MM. The basis for behavioral disturbances in dementia. J Neurol Neurosurg Psychiatry 1996; 61: 127-130.
25. Zubenko GS, Moosy J, Martínez J, Rao G, Claasen D, Rosen J et al. Neuropathological and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991; 48: 619-624.
26. Cummings JL, Kaufer D. Neuropsychyatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996; 47: 876-883.
27. Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T et al. Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 64: 648-652.
28. Lerner AJ, Koss E, Paterson MB, Ownby RL, Hedera P, Friedland RP et al. Concomitants of visual hallucinations in Alzheimer's disease. Neurology 1994; 44: 523-527.
29. Rosen J, Zubenko GS. Emergency of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiat 1991; 29: 224-232.
30. Sweet RA, Nimgaonkar VL, Kamboh MI, López LO, Zhang F, DeKosky ST. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch Neurol 1998; 55: 1335-1340.
31. López LO, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991; 41: 906-912.
32. López LO, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology 1997; 48: 1521-1525.
33. Starkestein SE, Vázquez S, Petracca G, Sabe L, Migliorelli R, Tesón A et al. A SPECT study of delusions in Alzheimer's disease. Neurology 1994; 44: 2055-2059.
34. Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47: 256-259.
35. López LO, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST. The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49: 794-797.